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ABSTRACT 
FDG-PET/CT is a widely established imaging modality for staging, restaging and monitoring therapy response in 
lymphoma  patients.  Progressive  transformation  of  germinal  centres  (PTGC)  is  a  benign  condition  presenting 
characteristically as asymptomatic lymphadenopathy. This paper presents a case of a 53-year-old man with a history of 
Hodgkin’s disease (HD) whose F
18 FDG-PET/CT scan showed high uptake in left axillary lymph nodes (SUV 3.8). A 
subsequent, left axillary lymph node biopsy revealed PTGC. PTGC can present as a false positive finding on FDG-
PET/CT in lymphoma patients and biopsy should be done in HD patients in clinical remission but have a positive FDG-
PET/CT scan. © 2008 Biomedical Imaging and Intervention Journal. All rights reserved. 
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CASE REPORT 
A  53-year-old  man  underwent  FDG-PET/CT 
scanning  for  detection  of  recurrent  disease.  He  was 
diagnosed with Hodgkin’s disease (HD) five years ago 
and successfully treated with chemotherapy. The patient 
was  asymptomatic.  12.6  mCi  FDG  was  injected  and 
images  acquired  using  a  Siemens  Biograph  6  PET-CT 
scanner (Siemens AG, Munich) (Figure 1). The PET/CT 
image showed small lymph nodes in the left axilla with 
the  highest  standardised  uptake  value  of  3.8  and 
measuring less than 1 cm in size. FDG-PET/CT imaging 
has been found to have higher accuracy than FDG-PET 
and CT alone in staging and restaging of patients with 
lymphoma [1,2].  
Left axillary lymph node biopsy was performed and 
revealed progressive transformation of germinal centres 
(PTGC).  Figure  2a  shows  progressive  transformed 
germinal  centre  and  loss  of  normal  architecture,  while 
Figure  2b  shows  small  lymphocytes,  histiocytes  and 
immunoblasts. 
DISCUSSION 
PTGC  was  initially  described  by  Lennert  and 
Muller-Hermerlink  as  large  follicles  composed 
predominantly  of  diffuse  small  lymphocytes  and  an 
obscured mantle zone [3]. PTGC is most commonly seen 
in  lymph  nodes  in  association  with  reactive  follicular 
hyperplasia  [4].  PTGC  may  precede  lymphocyte 
predominant  Hodgkin’s  disease  (LPHD)  or  can  be 
present  subsequently  in  lymph  node  biopsies  of 
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(a) 
 
(b) 
Figure 1  FDG PET-CT scan of the patient. Arrow shows small lymph nodes in the left axilla with the highest 
standardised uptake value of 3.8 and measuring less than 1 cm in size. 
 
 
 
 
 
 
(a) 
 
(b) 
Figure 2  Photomicrograph of left axillary lymph node biopsy (a) shows progressive transformed germinal centre 
and loss of normal architecture (haematoxylin and eosin stain, x10); (b) shows small lymphocytes, 
histiocytes and immunoblasts (haematoxylin and eosin stain, x40). 
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lymphoma patients
 as seen in this case; but the presence 
of PTGC is not associated definitively with an increased 
risk of developing HD [5]. 
The causes of false positive FDG-PET/CT include 
infection, inflammation, granulomatous disease [6,7] and 
immunisation [8]. However, the FDG uptake in PTGC 
has  been  rarely  documented  in  literature  [9]
  and  can 
present as a false positive finding on FDG-PET/CT scan. 
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